- Inactivated poliomyelitis vaccine developed by Sinopharm gains WHO’s pre-qualification2022-03-02
- NMPA Notice on Launching the Cosmetic Ingredient Safety Information Registration Platform2022-02-25
- NMPA Announcement on the Good Manufacturing Practice for Cosmetics2022-02-25
- NMPA Announcement on Trial Operation of Electronic Registration Certificate for Cosmetics2022-02-25
- NMPA Announcement on Two Guidelines for Registration Review of Drug-Device Combination Pro...2022-02-25
- NMPA Announcement on the Emergency Approval Procedure for Medical Devices2022-02-25
- NMPA Announcement on the Technical Guideline for the Revision of Safety Information Items ...2022-02-25
- Notice of the Center for Drug Evaluation of NMPA on the Applicability of E2B (R3) Regional...2022-02-25
- Notice of the Center for Drug Evaluation of NMPA on Issues related to the Implementation o...2022-02-25
- NMPA held a working conference on the TCM quality and safety regulation2022-02-25